Decreased Cardiac Autonomic Function is Associated with Higher Exacerbation Risk and Symptom Burden in Chronic...

Area of Science:

• Cardiology
• Pulmonology
• Biomarkers

Background:

• Current chronic obstructive pulmonary disease (COPD) severity measures inadequately predict symptom burden and exacerbation risk.
• Autonomic dysfunction is increasingly recognized for its role in cardiovascular and respiratory complications in COPD.
• Heart rate variability (HRV) shows promise as a non-invasive biomarker for cardiovascular health and potentially for COPD.

Purpose of the Study:

• To investigate the association between HRV and COPD morbidity, including symptom burden and exacerbation risk.
• To explore HRV as a potential non-invasive biomarker for identifying high-risk COPD populations.

Main Methods:

• The CLEAN AIR Heart study enrolled 85 former smokers with moderate-severe COPD.
• Participants underwent repeated clinical assessments and 24-hour Holter monitoring for HRV measurements (SDNN and RMSSD).
• Statistical models analyzed associations between HRV, exacerbation risk, and symptom scores (SGRQ, CAT).

Main Results:

• Decreased SDNN and RMSSD were significantly associated with increased risk of severe exacerbations.
• Lower SDNN correlated with higher symptom burden, including worse St George's Respiratory Questionnaire and COPD Assessment Test scores, and chronic bronchitis symptoms.
• These findings indicate a clear link between HRV metrics and COPD clinical outcomes.

Conclusions:

• HRV is associated with both symptom burden and exacerbation risk in patients with moderate-severe COPD.
• HRV may serve as a valuable non-invasive biomarker for identifying COPD patients at higher risk for adverse events.
• Further research into HRV could refine COPD management strategies and risk stratification.